At UCB our sense of purpose is to help people suffering from severe central nervous system or immunological disorders lead normal, everyday lives. Our ambition is to offer them innovative new medicines and ground-breaking solutions that go beyond the drug. We are committed to enabling cutting-edge scientific research that is driven by the patients' needs.

UCB, headquartered in Brussels, Belgium, is a global biopharma company with a team of more than 8,000 talented employees, a strong market presence in about 40 countries, € 3.2 billion in revenue (2011) and numerous strategic partnerships across the industry.